Supplies will be extremely limited between week commencing 5th October until early December 2020 and reserved for primary care only. Pfizer is supplying an alternative presentation of lorazepam from the US during this time to support this out of stock period (lorazepam 2mg/ml [Carpuject™] single dose cartridges), which is considered unlicensed in the UK. This memo advises on potential alternative agents that might be considered for use in the absence of a licensed version of lorazepam injection and if unlicensed lorazepam 2mg/ml single dose cartridges (Carpuject™) are not deemed appropriate. It should be noted that currently, there is also an ongoing supply issue with Diazemuls.
See Medicines Supply Notification (MSN) for further information.